- Home
- NPT vs BTMD Comparison
NPT vs BTMD Comparison
Compare NPT & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NPT | BTMD |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.2M | 65.8M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NPT | BTMD |
|---|---|---|
| Price | $2.72 | $2.25 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.83 |
| AVG Volume (30 Days) | 131.9K | ★ 411.9K |
| Earning Date | 05-23-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 722.22 |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $192,219,000.00 |
| Revenue This Year | N/A | $2.03 |
| Revenue Next Year | N/A | $6.58 |
| P/E Ratio | ★ N/A | $39.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.14 | $1.27 |
| 52 Week High | $22.38 | $4.75 |
Technical Indicators
Market Signals| Indicator | NPT | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 52.96 | 51.74 |
| Support Level | $2.20 | $1.97 |
| Resistance Level | $3.21 | $2.44 |
| Average True Range (ATR) | 0.29 | 0.17 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 29.57 | 74.16 |
Price Performance
Historical ComparisonAbout NPT Texxon Holding Limited Ordinary shares
Texxon Holding Ltd provides technology-enabled supply chain management services to customers in the plastics and chemical industries in East China. The company operates through two segments: Supply Chain Trading and Plastic Manufacturing. Its services include procurement, logistics, payments, and fulfillment for Chinese SMEs, and all revenue is generated from operations within the People's Republic of China.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.